Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-128621
Filing Date
2024-11-19
Accepted
2024-11-19 16:18:50
Documents
90
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q emma-20240930.htm   iXBRL 10-Q 2963685
2 EX-10.1 emma-ex10_1.htm EX-10.1 508916
3 EX-31.1 emma-ex31_1.htm EX-31.1 11949
4 EX-31.2 emma-ex31_2.htm EX-31.2 12038
5 EX-32.1 emma-ex32_1.htm EX-32.1 10628
6 GRAPHIC img109337448_0.jpg GRAPHIC 2073
7 GRAPHIC img109337448_1.jpg GRAPHIC 9477
8 GRAPHIC img109337448_2.jpg GRAPHIC 1112
9 GRAPHIC img109337448_3.jpg GRAPHIC 3679
10 GRAPHIC img109337448_4.jpg GRAPHIC 707
11 GRAPHIC img109337448_5.jpg GRAPHIC 3039
12 GRAPHIC img109337448_6.jpg GRAPHIC 1113
13 GRAPHIC img109337448_7.jpg GRAPHIC 1510
14 GRAPHIC img109337448_8.jpg GRAPHIC 1253
15 GRAPHIC img109337448_9.jpg GRAPHIC 1510
16 GRAPHIC img109337448_10.jpg GRAPHIC 1253
17 GRAPHIC img109337448_11.jpg GRAPHIC 1775
18 GRAPHIC img109337448_12.jpg GRAPHIC 3983
  Complete submission text file 0000950170-24-128621.txt   15445638

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT emma-20240930.xsd EX-101.SCH 1797262
92 EXTRACTED XBRL INSTANCE DOCUMENT emma-20240930_htm.xml XML 3606452
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

EIN.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35527 | Film No.: 241476391
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)